Kindred Biosciences announces pricing of public offering
Kindred Biosciences announced pricing of an underwritten public offering of 4,215,000 shares of its common stock at a public offering price of $9.50 per share, for gross proceeds of $40,042,500. KindredBio granted underwriters a 30-day option to purchase up to an additional 632,250 shares. January 18, 2019